Lilly Insulin Value Cash Card

Based on the information you have provided, you may be eligible to use the Insulin Value Copay Card. This card may help you pay as little as $35 per 30-day prescription for each Lilly insulin product.

Co-pay cards can help lower the out-of-pocket amount you pay at the pharmacy counter. You must have a valid prescription for each Lilly insulin product.

  • Click here: https://www.insulinaffordability.com/ to download this Lilly Insulin Value Copay Card.
  • Because you provided that you pay cash for your Lilly insulin, make sure to click the “I pay cash” after checking the confirmation boxes. You will then click “Download Your Card.”
  • Give this information to the pharmacy (in person or by telephone) so they can add the savings program into their payment system before you pick up your prescription.
  • If the pharmacy has trouble processing your Lilly Insulin Value Savings Card, make sure they have called the pharmacy help line at 1-800-282-4888.

Additional Resources

About Getinsulin.org

GetInsulin.org is a resource for those struggling to access insulin today. Since 2013, the list price of insulin has skyrocketed, leaving some without health insurance or on high-deductible insurance plans paying out-of-pocket upwards of $1,000 for a one-month supply of insulin, often unaware of assistance options. This is the result of a unique drug pricing crisis going on in the United States that will require widespread healthcare reform to bring list prices down. In the immediate term, people in the US need to know what their options are to access insulin.

GetInsulin.org is a program of Beyond Type 1, an organization that advocates for high quality, modern insulin to be available to people with diabetes regardless of employment or insurance status, across all demographics, without barriers, and at an affordable and predictable price point. Until that is achieved, GetInsulin.org is a tool for those needing access to insulin options immediately.

Sponsors

GetInsulin.org is a resource of Beyond Type 1 with support from Lilly, Novo Nordisk, and Sanofi